Microbial Testing for Raw Botanical Ingredients: What USP <61>, <62>, and <1111> Actually Require

Many supplement quality managers have reviewed hundreds of botanical raw material COAs without realizing that the two most important numbers on the document — TAMC and TYMC results — are meaningless without a third piece of information that’s often missing entirely. That missing piece is the USP acceptance category, and its absence is one of the most common and consequential oversights in incoming material control for botanical ingredients.

FDA Warning Letters to dietary supplement firms consistently cite inadequate testing of raw botanical ingredients as a top cGMP violation, and the pattern is rarely about labs cutting corners. More often, it’s a systemic misunderstanding of how USP’s microbiology chapters interact. Fixing that misunderstanding starts with understanding that USP <61>, <62>, and <1111> are three distinct chapters that only work correctly when applied together.

USP <61> and <62> Are Test Methods, Not Acceptance Standards

This is the most pervasive misconception in botanical quality control. USP <61> (Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests) and USP <62> (Tests for Specified Microorganisms) describe how to perform the tests. They specify which growth media to use, what incubation temperatures and timeframes apply, how to calculate colony-forming units per gram. What they deliberately do not do is tell you whether your result passes or fails.

That determination belongs to USP <1111> (Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use). And this distinction matters more for botanical ingredients than for almost any other category of dietary supplement input.

When a supplier’s COA references USP <61> and lists a Total Aerobic Microbial Count (TAMC) result, that number is scientifically valid — but contextually incomplete. A TAMC of 4.5 × 10⁵ CFU/g may be perfectly acceptable for a bulk herb material destined for extraction, while representing a significant out-of-specification result for the same material going into a finished encapsulated product for direct consumption. Same method. Same number. Two entirely different quality verdicts, depending on which <1111> category applies.

Every credible analytical testing laboratory should be documenting both the test method and the applicable <1111> acceptance category on the final COA. If you’re routinely receiving supplier documents that show a number but not the standard it was evaluated against, you have a documentation gap — and almost certainly a supplier oversight program that will struggle under FDA inspection.

How USP <1111> Classifies Botanical Ingredients — and Why Category Is Everything

USP <1111> organizes non-sterile products into acceptance categories with substantially different microbial thresholds. For herbal and botanical materials, the critical distinction is between materials that undergo a kill step before consumption (such as a tea prepared with boiling water) versus materials consumed directly in their processed form (extracts, encapsulated powders, tinctures).

For herbal substances to which boiling water is added before use, the chapter permits a TAMC up to 10⁷ CFU/g and a Total Yeast and Mold Count (TYMC) up to 10⁵ CFU/g. The rationale is straightforward: brewing with near-boiling water provides a meaningful pathogen-reduction step that mitigates the risk of high background bioburden in unprocessed plant material.

For other herbal preparations — powders, extracts, and ingredients going into finished dosage forms — the limits are considerably tighter, and the difference between these two categories can be as much as 100-fold on the TAMC limit alone. A bulk turmeric root powder bought for blending into a loose-leaf tea formulation and that same material reformulated as a capsule ingredient fall into different acceptance categories under <1111>, even if they’re from the same lot.

The practical consequence for Midwest supplement brands: many incoming botanical COAs from overseas suppliers don’t specify which <1111> category was applied to determine the pass/fail call. The supplier may have used the correct limits for their application, but you cannot assume that their application matches yours. If you’re buying elderberry extract powder as a raw material for encapsulation and the supplier evaluated it against the limits appropriate for tea ingredients, that COA provides false assurance.

For specified organisms under USP <62>, the stakes compound further. Botanicals sourced from South and Southeast Asia, and from parts of East Africa and Latin America, have a documented history of Salmonella contamination. FDA’s Center for Food Safety and Applied Nutrition has traced supplement-related illness clusters back to botanical raw materials including black pepper, cumin, paprika, and various Ayurvedic root preparations. USP <62> requires absence of Salmonella spp. in a 10g sample. The question your incoming COA should answer isn’t just whether the test was performed — it’s whether the tested sample size and sampling plan were appropriate for the lot being released.

Why Botanical Raw Materials Are a Microbiology Challenge by Nature

Plants are agricultural products. They grow in soil, are harvested outdoors, dried in variable conditions, and move through multi-step international supply chains before arriving at a Midwest warehouse. High bioburden isn’t a defect in raw botanical materials — it’s the baseline state of unprocessed plant tissue, and any analytical testing laboratory experienced in this category knows to expect it.

The challenge for supplement brands is distinguishing between expected background bioburden and pathogen presence. A freshly dried ginger root or ashwagandha root powder might carry 10⁶ to 10⁷ CFU/g of total aerobic organisms straight from the drying facility. That’s not automatically disqualifying. What matters is what’s in that count — and whether specified pathogens are present.

Water activity complicates things further. A turmeric powder dried to 10% moisture will typically show a TYMC three to five times higher than an identically sourced lot dried to 6% — under identical USP <61> test conditions. Both lots may meet specification. Both may come from the same crop and the same region. But TYMC tells a very different story depending on how the material was handled post-harvest. Water activity at the time of testing, not just moisture content, is a meaningful predictive variable that most incoming testing programs don’t track.

Transit conditions matter as well. A container that ships from India in May and arrives at a Chicago facility in August has passed through temperature and humidity gradients that affect bioburden. Lots receiving microbial testing at origin, then sitting in port storage and ocean transit for 6–8 weeks, can arrive with measurably different microbial profiles than their pre-shipment COA reflects. At our Chicago receiving facility, roughly 25–30% of incoming botanical lots that we retest show TAMC or TYMC results higher than the supplier COA — the majority of the time, this traces to transit moisture exposure, not supplier misrepresentation. It’s physics, not fraud. But that distinction doesn’t make it acceptable to use without the data.

What a Properly Documented Microbiology COA Should Show

When you’re reviewing a supplier’s microbial COA or commissioning incoming verification testing through an analytical testing laboratory, there are six data points that should be present and clearly legible:

Test method citation: USP <61> for enumeration counts, USP <62> for specified organisms. In-house methods should be flagged unless the supplier can provide equivalency data against the USP harmonized methods.

USP <1111> acceptance category: The COA must state which product category table was used to determine pass/fail limits. Without this, the result is uninterpretable for your application.

Quantitative TAMC and TYMC results with units: CFU/g, not “Pass” or “Compliant.” A headline pass/fail is not a data point. It’s an assertion. The numeric result is what you need to assess lot-to-lot variability, trending, and appropriateness for your formulation.

Specified organism results by organism: At minimum, absence of Salmonella spp. per 10g and absence of E. coli per 1g for most botanical ingredients destined for finished supplement dosage forms. Some product categories require additional specified organisms under <62>; your quality specification should define this, not your supplier’s default panel.

Dilution factor used in enumeration: High-bioburden botanicals are typically tested at a 1:20 or greater dilution under <61>. A result of 1.0 × 10³ CFU/g without documented dilution information could reflect a low-count material — or it could reflect a 1:1000 dilution that obscures the true count. Reputable analytical testing laboratories include method detail, not just headline numbers.

Date of testing relative to lot receipt: A COA dated more than 90 days before your incoming shipment should trigger retest rather than acceptance, particularly for high-bioburden materials stored in variable-humidity environments during transit. This isn’t excessive caution — it’s what 21 CFR Part 111’s incoming testing provisions were written to address.

Building a Botanical Incoming Control Program That Holds Up Under FDA Scrutiny

Under 21 CFR Part 111, §111.75 requires verification of identity and purity of dietary ingredient components before use. FDA has consistently interpreted “purity” to include microbial quality for botanical ingredients — and Form 483 observations for inadequate incoming ingredient testing appear with enough regularity that they’re not edge cases. They’re the norm for firms that rely entirely on supplier-furnished documentation.

A practical incoming control program for botanical raw materials should include identity verification (at minimum, visual organoleptic and HPTLC confirmation that the material is authentic), incoming microbial retest on each new supplier production lot where historical retest data from that supplier is fewer than 12 months old, and targeted pathogen testing for high-risk materials. Ashwagandha, for example, has appeared in FDA import alerts; root powders from regions with documented Salmonella contamination history warrant Salmonella and Shiga toxin-producing E. coli (STEC) testing on every new supplier lot, not just initial qualification.

A water activity meter at the receiving dock — a basic benchtop unit runs approximately $300 to $500 — eliminates one of the largest variables in botanical bioburden prediction. Measuring water activity at receipt, before the lot is stored, gives you a real-time indicator of microbial risk that no supplier COA can provide.

When a lot fails incoming microbial limits, the options are rejection, validated reprocessing (if your formulation allows for a kill step with documented log-reduction data), or documented risk-based disposition. None of those decisions can be made responsibly without accurate quantitative results from an accredited analytical testing laboratory — not because the regulation demands it, but because the data is the only thing that gives your quality team the information to make the right call.

The next time a botanical raw material COA lands on your desk, ask two specific questions before filing it: Which USP <1111> category was used to evaluate this TAMC result? And when was this lot actually tested relative to the shipment you’re receiving? If those answers aren’t on the document, you’re holding a partial COA — and making incoming quality decisions on incomplete information. That’s not a compliance gap you want an FDA investigator to find first.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• How ISO 17025-Accredited Labs Approach Botanical Raw Material Testing — A look at the accreditation standards behind the microbial and identity testing methods used for herbal ingredient qualification.
• Understanding USP <61>/<62> Method Validation at an Accredited Contract Lab — What method suitability testing for high-bioburden botanical matrices actually involves, from a California ISO 17025-accredited laboratory’s perspective.